Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
CA 2648051 A1 · Owner: Gerber, Hanspeter · Inventors: Gerritsen, Mary E.; Williams, P. Mickey; Ye, Weilan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods are disclosed for stimulating or inhibiting angiogenesis , and/or cardiovascularization in mammals including humans. Pharmaceutical , compositions are based on polypeptides or antagonists thereto that have been identified , for one or more of these uses. Disorders that can be diagnosed prevented, or , treated by , the compositions herein include trauma such as wounds various cancers, and , disorders , of the vessels including atherosclerosis and cardiac hypertrophy.In addition the present , invention is directed to novel polypeptides and to nucleic acid molecules encoding those , polypeptides. Also provided herein are vectors and host cells comprising those …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 20, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 20, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 20, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.